{
  "id": 4878551,
  "title": "GSK to launch Phase 3 test of mRNA flu vaccine with newer formulation",
  "url": "https://urgent.news/2026/09/01/gsk-to-launch-phase-3-test-of-mrna-flu-vaccine-with-newer-formulation",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-01T14:40:34.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/gsk-to-launch-phase-3-test-of-mrna-flu-vaccine-with-newer-formulation/"
  },
  "original_language": "en",
  "account": null,
  "summary": "GSK on Tuesday said it will start a late-stage trial of its mRNA vaccine for seasonal influenza after the candidate delivered “higher immune responses” than traditional vaccines in a Phase 2 test. The UK pharma ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Seeking Alpha News",
        "title": "GSK to advance mRNA seasonal flu vaccine to phase 3 trial",
        "url": "https://urgent.news/2026/09/01/gsk-to-advance-mrna-seasonal-flu-vaccine-to-phase-3-trial",
        "published": "2026-09-01T06:33:13.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}